China conditionally approves four self-developed COVID-19 vaccines: official
21:51 UTC+8, 2021-02-26
0
China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
21:51 UTC+8, 2021-02-26
0
Xinhua
A medical worker prepares a vaccine at a temporary COVID-19 vaccination site at a company in the ZPark Phase 2 in Haidian District of Beijing, capital of China on February 22, 2021.
China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
Source: Xinhua
Editor: Chen Xiaoli
Special Reports
